Clin2
NCT07548632Likely a fitRecruiting

Testing a new eye drop medicine for dry eye disease

Dry Eye Disease (DED)

Part of Eyes & vision clinical trials.

This study tests whether licaminlimab, a new type of eye drop medicine, helps relieve dry eye disease. You'll use the study medicine for several weeks while doctors track how your symptoms and eye health improve.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
160 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have been diagnosed with dry eye disease by a doctor within the last 6 months
  • You currently use over-the-counter artificial tears or eye drops
  • You are willing to have a simple genetic test (a cheek swab or blood sample)
  • You do not have other eye conditions or health problems that could interfere with the study
  • You must be able to commit to study visits and follow all instructions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07503886Recruiting· Phase 2
Study of an eye drop for dry eye disease

This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.

Chandler, Arizona
NCT07068958Not yet recruiting· Phase 2
A study testing a new eye drop for dry eye

This trial tests a new eye drop called RCI001 to see if it works better than a placebo for people with dry eye. You may be able to join if you have had dry eye for at least 6 months and have certain signs of dry eye during exams.

NCT07369375Not yet recruiting
Testing New Eye Drops for Dry Eye Disease

This study tests new eye drops for people with mild to moderate dry eye disease. It will check how well the drops work and if they are safe over time.

NCT07078955Not yet recruiting· Phase 2
Testing a new eye drop for dry eye disease

This study tests different doses of an investigational eye drop (BRM421) to see if it safely helps people with dry eye disease. It may be an option if you have had dry eyes for a while and are looking for a new treatment.

New Taipei City
NCT06879782Recruiting· Phase 3
Eye drops for dry eye disease: a phase 3 study

This study tests an eye drop called lifitegrast for people with dry eye disease. It looks at whether the drops can improve eye comfort, reduce dryness, and help eye surface health. You may be able to join if you have had dry eye symptoms and used artificial tears in the past month.

Beijing, Beijing Municipality
NCT06633471Not yet recruiting· Early Phase 1
Evaluating a new artificial tear for dry eye disease

This study tests a new eye drop formula to see if it safely improves dry eye symptoms. It may be a good option if you have been diagnosed with dry eye and have limited tear production.

Bridgetown

Hear when a new Dry Eye Disease (DED) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.